What can we say? We’ve got Pharma on the mind this week! On Monday Mark offered commentary on the latest “study” being spun to further promote statins to the general population. It seemed like an opportune time to bring you news of a recent report on the “unofficial” business of off-label pharmaceutical marketing and the clever manipulation of drug approval rules and research dissemination.
Two researchers with significant experience in the pharmaceutical industry, Adriane Fugh-Berman, M.D., an associate professor in the GUMC Department of Physiology and Biophysics, and Douglas Melnick, M.D., a preventive medicine physician in the Los Angeles County Department of Public Health have published a report in the free online journal PLoS Medicine shedding light on risky and legally questionable practices that have become commonplace in the industry.